scieee Open visual document viewer

Failure in Implant Rehabilitation in a Patient With Severe Congenital Neutropenia (Kostmann Syndrome)

Marín Berná, Marian; Velázquez Cayón, Rocío Trinidad; Torres-Lagares, Daniel; Hita Iglesias, Pilar; Bouferrache, Kahina; Madrid, Carlos; Gutiérrez Pérez, José Luis

Abstract

Introduction .- Kostmann syndrome is an autosomal recessive disorderthat precipitates severe congenital neutropenia (SCN). One of the most characteristic oral manifestations of this syndrome is severe periodontal disease with extensive bone loss in the primary dentition. This bone loss often extends into the permanent dentition leading to premature partial or total edentulism. Objective.- This paper will review, discuss, and document the indications of implant placement as well as the dental and medical management of periimplant infective complications in a patient with Kostmann syndrome. Case report.- The dental management of patients with SCN has been poorly described in the literature thus far. In this paper we report a case of dental implant failure in a 24 years old patient diagnosed with Kostmann syndrome. This patient underwent implant supported rehabilitation with 8 upper maxilla and 4 mandible dental implants and returned to the Hospital 5 months post-operatively with an implant related submandibular abscess ultimately requiring removal of the mandibular implants despite extended IV antibiotics therapy. Discussion.- There is currently no available data to guide the use of dental implants in patients affected from Kostmann disease. We believe the most likely cause of infective oral complications in this patient population occurs during the surgical stages of implant placement as this genetic immunodeficiency likely allows for increased ability of opportunistic oral microflora to colonize the implant surface as well as the oral soft and hard tissues.

Full text

“Failu e in implan ehabili a ion in a pa ien wi h Se e e Congeni al Neu openia” AUTHORS: Ma ín-Be ná M (1), Velázquez-Cayón RT (2), To es-Laga es D (3), Hi a- Iglesias P (4), Bou e ache K (5), Mad id C (6), Gu ie ez-Pe ez JL (7) (1) Mas e in O al Suge y. Uni e si y o Se ille. (2) Mas e in O al Suge y. Uni e si y o Se ille. (3) P o esso o O al Su ge y. Uni e si y o Se ille. (4) Clinical Assis an P o esso o O al and Maxillo acial Su ge y. Uni e si y o Michigan. (5) P o eso o he Depa men o O al Medicine, O al Su ge y and Hospi al Den is y. Uni e si y o Lausanne Medical School (6) Head o he Depa men o O al Medicine, O al Su ge y and Hospi al Den is y. Uni e si y o Lausanne Medical School (7) Head P o esso o O al Su ge y. Uni e si y o Se ille. ABSTRACT In oduc ion .- Kos mann synd ome is an au osomal ecessi e diso de ha p ecipi a es se e e congeni al neu openia (SCN). One o he mos cha ac e is ic o al mani es a ions o his synd ome is se e e pe iodon al disease wi h ex ensi e bone loss in he p ima y den i ion. This bone loss o en ex ends in o he pe manen den i ion leading o p ema u e pa ial o o al eden ulism. Objec i e.- This pape will e iew, discuss, and documen he indica ions o implan placemen as well as he den al and medical managemen o pe i- implan in ec i e complica ions in a pa ien wi h Kos mann synd ome. Case epo .- The den al managemen o pa ien s wi h SCN has been poo ly desc ibed in he li e a u e hus a . In his pape we epo a case o den al implan ailu e in a 24 yea s old pa ien diagnosed wi h Kos mann synd ome. This pa ien unde wen implan suppo ed ehabili a ion wi h 8 uppe maxilla and 4 mandible den al implan s and e u ned o he Hospi al 5 mon hs pos -ope a i ely wi h an implan ela ed submandibula abscess ul ima ely equi ing emo al o he mandibula implan s despi e ex ended IV an ibio ics he apy. Discussion.- The e is cu en ly no a ailable da a o guide he use o den al implan s in pa ien s a ec ed om Kos mann disease. We belie e he mos likely cause o in ec i e o al complica ions in his pa ien popula ion occu s du ing he su gical s ages o implan placemen as his gene ic immunode iciency likely allows o inc eased abili y o oppo unis ic o al mic o lo a o colonize he implan su ace as well as he o al so and ha d issues. Key wo ds: Kos mann Synd ome, Se e e congeni al neu openia, Implan ailu e, Sys emic disease “Failu e in implan ehabili a ion in a pa ien wi h Se e e Congeni al Neu openia” INTRODUCTION I is well known ha a ious d ug ea men s and sys emic diseases may comp omise he in eg i y o he o al issues. Likewise hese condi ions may also a ec he iabili y o den al implan s and hei su ounding issue [1]. While ecommenda ions exis o he a oidance o den al implan s wi h ce ain sys emic diseases [2], he scien i ic e idence o suppo such guidance is lacking. Mo eo e , es ima ing he isk o implan ailu e in hese pa ien popula ions is challenging as o en hese pa ien s a ely ecei e endo-osseous implan s [3]. Se e e congeni al neu openia is one such disease ha may a ec he su i al a e o den al implan s [4]. SCN, also known as Kos mann synd ome, is inhe i ed in ei he an au osomal ecessi e (HAX-1 mu a ion) o au osomal dominan (ELA-2 mu a ion) manne [6]. The es ima ed incidence o SCN is 1-2 cases pe million wi h equal dis ibu ion among gende s [5]. The condi ion is usually diagnosed in he pe ipa um pe iod and p esen s wi h impai ed bone ma ow myelopoiesis and a ch onic absolu e neu ophil coun (ANC) less han 500/μL. Bone ma ow examina ion o en e eals p omyelocy e / myelocy e a es wi h li le e idence o ma u e g anulocy e o ma ion. Mos pa ien s wi h SCN, including hose wi h Kos mann synd ome, a e success ully ea ed wi h g anulocy e colony s imula ing ac o (G-CSF). T ea men can lead o a 10-12 old inc ease in neu ophil coun and esul s in a highe li e expec ancy o pa ien s wi h congeni al neu openia [7]. Un o una ely, a ound 10% o pa ien s do no espond o his he apy. T ea men wi h G-CSF has imp o ed he con ol o li e- h ea ening bac e ial in ec ions p e iously common in hese indi iduals. The mos common in ec ions a ec ing hese pa ien s a e median o i is, cu aneous celluli is, pe i ec al abscesses, u unculi is, pneumonia, s oma i is, se e e pe sis en gingi al in lamma ion and a ious uppe espi a o y in ec ions, [9]. Pa ien s wi h SCN may also p esen wi h pe iodon i is [5]. Pe iodon al mani es a ions ange om ma ginal gingi i is o apidly p og essi e pe iodon al disease wi h ad ancing al eola bone loss a ec ing bo h p ima y and pe manen den i ion. Full mou h ehabili a ion using implan s in pe iodon ally heal hy pa ien s has been well documen ed [10]. Howe e , implan he apy in pe iodon i is- suscep ible indi iduals has been ques ioned. Pe iodon al pa hogens may comp omise he success a e o implan he apy in pa ially eden ulous pa ien s. Pe iodon al pa hogens we e adi onally belie ed o ha e been elimina ed wi h he ex ac ion o all na u al ee h. The e o e an eden ulous pa ien wi h a his o y o pe iodon i is was conside ed an app op ia e candida e o den al implan placemen . Con a y o his belie , ecen esea ch on bac e ial lo a in pa ien s who ha e been eden ulous o a leas one yea showed he p esence o mul iple pe iodon al pa hogens such as Ac inomyces sp and Po phy omonas gingi alis [11]. Den al managemen , including he applica ion o den al implan he apy, in pa ien s wi h SCN has been poo ly documen ed in he li e a u e hus a . We epo he i s case o ixed ull mou h ehabili a ion in a 24-yea -old pa ien wi h Kos mann synd ome diagnosed a 18 mon hs o age. CASE STUDY CASE STUDY The pa ien was diagnosed wi h omphali is a he age o ou mon hs and was subsequen ly a ec ed a sho in e als by a se ies o in ec ious diseases such as ecu en se e e o i is, o al ulce s, campilobac e gas oen e i is, cu aneous muco mycosis and uppe and lowe espi a o y ac in ec ions leading o pneumonia. Pe iphe al blood hemog am and bone ma ow aspi a e showing ma u a ion a es and mu a ion o HAX-1 gene led o a inal diagnosis o Kos mann synd ome a age 18 mon hs . The pa ien ’s diagnosis and ea men was ca ied on a he Uni e si y Hospi al Vi gen del Rocío in Se ille. A he age o 7, he pa ien had comple e ex ac ion o he p ima y den i ion due o he p esence o ch onic gingi i is, gene alized gingi al ecession and g ade III mobili y. Du ing he pa ien ’s la e adolescence, he pa ien had ch onic un ea ed pe iodon al disease leading o he p og essi e loss o he pe manen den i ion and was comple ely eden ulous a he age o 22 yea s. The inal ea men plan consis ed o a ull-mou h implan ehabili a ion a e a a o able clinical and adiological assessmen . The implan ea men planning consis ed o a o al o eigh maxilla y implan s o suppo a ixed p os he ic ehabili a ion, and 4 mandibula implan s o s abiliza ion o an o e den u e (Figu e 1). A ound he hi d pos ope a i ely pe iod he pa ien de eloped local in ec ious symp oms consis en wi h pe i-implan i is and he subsequen loss o one mandibula implan . Mild o al local signs o in ec ion pe sis ed o ou mon hs despi e con inuous o al an ibio ic he apy. A mon h 5 pos ope a i ely he pa ien de eloped acu e onse o dysphagia and dis ess upon swallowing equi ing hospi al admission. The diagnosis was consis en wi h implan - ela ed submandibula abscess. The ea men included su gical incision, deb idemen and d ainage ia pen ose ube h ough he sup ahyoid egion and daily in a enous in usion o an ibio ics ( ob amycin 200mg and clindamycin 600mg) o a o al o 4 days. Speci ic an ibio ic he apy was selec ed acco ding o he esul s o an an ibiog am a e isola ion o wo possible causa i e bac e ias (S ep ococcus in e medius and P e o ella). (Table 1) Two days a e admission he emaining mandibula implan s we e emo ed. Full blood coun (Table 2) showed a sligh ly low o al whi e blood cell coun (< 2.78 x 109L). Di e en ial whi e blood cell coun showed leukopenia mainly associa ed wi h o al absence o neu ophils and pa ially hidden by eosinophilia and monocy osis speci ic o Kos mann synd ome. Th ee mon hs pos ope a i ely, o al and adiog aphic exams we e aken demons a ing an asymp oma ic, ully healed disease- ee mandibula a ch. DISCUSSION Implan ology is unde going a con inuous ans o ma ion ega ding wha a e conside ed ela i e and absolu e con aindica ions o implan he apy. Some con o e sy exis s on he signi icance o sys emic diso de s as isk ac o s o den al implan s ou come. While a ious sys emic diso de s and medical he apies ha e been epo ed o po en ially comp omise he s abili y o den al implan s, he e is li le e idence o suppo such associa ion since only ew s udies compa e he occu ence o hese diso de s wi hin a con olled en i onmen [1, 3]. The use o den al implan s in ol es b eaking a de ensi e ba ie such as he o al mucosa, wi hin a habi a ich in bac e ial lo a. Since his ype o pa ien s o en p esen s wi h uns able immune sys ems, e en when hey a e ecei ing app op ia e ea men , [15, 16,17] i would be ad isable o weigh ca e ully he cos /bene i o implan su ge y and he ange o he apeu ic op ions should be me iculously assessed in ela ion o he pa ien ’s condi ion. In ou case epo , he pa ien p esen s wi h SCE, a a e haema ologic immune diso de commonly associa ed wi h se e e pe iodon i is. Va ious diso de s such Papillon-Le e e synd ome, Down synd ome, Ehle s-Danlos synd ome, Lange hans cell his iocy osis, Chediak-Higashi synd ome, hypophospha emia, and Leukocy e adhesion de iciency ha e also been epo ed o p esen in associa ion wi h gene alized pe iodon i is [4, 12, 13] Thus, pe iodon al disease could be conside ed as a signi ican igge o ea ly diagnosis o an unde lying sys emic disease due o i s i ulence in his ype o pa ien s. The p esen case s udy is no esol ed wi h he emo al o lowe jaw emnan implan s, because as we can obse e in he di e en pano amic X- ays, uppe implan s show bone loss o app oxima ely mo e han hal he size o he implan . These implan s will be e ised in successi e ollow-up isi s in o de o o e a mo e accu a e assessmen o he p esen case epo . Despi e he lack o scien i ic e idence ega ding he possibili y o implan ehabili a ion in pa ien s wi h hese diso de s, i would be easonable o hink ha suscep ibili y o pe iodon i is associa ed o sys emic diso de s migh ha e a nega i e in luence on he ou come o implan he apy. [14] Al hough we a e conscious o he bias posed by he publica ion o posi i e ou comes in clinical s udies and small se ies, in hose cases in which he medical condi ions a e so se ious ha implan he apy has no been well- documen ed ye , i is ex emely di icul o o e a highe le el o e idence [1]. Occasionally, he indica ion o o al implan s should be ho oughly e alua ed in pa ien s wi h local o sys emic isk ac o s ha may in e e e wi h he implan ea men s abili y. [18] REFERENCES 1.Bo ns ein MM, Cionca N, Mombelli A. Sys emic condi ions and ea men s as isks o implan he apy. In J O al Maxillo ac Implan s 2009; 24(suppl):12- 27. 2. Suge man PB, Ba be MT. Pa ien selec ion o endosseous den al implan s: O al and sys emic conside a ions. In J O al Maxillo ac Implan s 2002; 17: 191-201. 3. Mombelli A, Cionca N. Sys emic diseases a ec ing osseoin eg a ion he apy. Clin O al Imp Res 2006; 17(suppl.2):97-103. 4. Solleci o TP, Sulli an KE, Pin o A, S ewa d J, Ko os o J. Sys emic condi ions associa ed wi h pe iodon i is in childhood and adolescence. A e iew o diagnos ic possibili ies. Med O al Pa ol O al Ci Bucal. 2005;10: 142-50. 5. C. Zeidle , L. Boxe , D. C. Dale, M. H. F eedman, S. Kinsey and K. Wel e. Managemen o kos mann synd ome in he g-cs e a. B J Haema ol 2000; 109: 490-5) 6. Boxe LA, S ein S, Buckley D, Bolya d AA, Dale CC. S ong e idence o au osomal dominan inhe i ance o se e e congeni al neu openia associa ed wi h ELA2 mu a ions. J Pedia 2006; 148: 633-6). 7. Bux J, Dickmann JO, S ocke U, Muelle - Eckha d C. In luence o g anulocy e an ibodies on g anulocy e unc ion Vox Sang 1993; 64: 220-5). 8. Ca lsson G, Wahlin YB, Johansson A, Olsson A, E iksson T, Claesson R, Häns öm L, Hen e JI. Pe iodon al disease in pa ien s om he o iginal Kos mann amily wi h se e e congeni al neu openia. J Pe iodon ol 2006;77:744-751. 9. Okada M, Kobayashi M, Hino T, Ku iha a, Miu a K. Clinical Pe iodon al Findings and Mic o lo a P o iles in Child en Wi h Ch onic Neu openia Unde Supe ised O al Hygiene. J Pe iodon ol, 2001; 72: 945-52 10. Alb ek sson T, Za b G, Wo hing on P, E iksson AR. The long- e m e icacy o cu en ly used den al implan s: a e iew and p oposed c i e ia o success. In J O al Maxillo ac Implan s. 1986;1:11–25). 11. Sachdeo A, Ha ajee AD, Soc ansky SS. Bio ilms in he eden ulous o al ca i y. J P os hodon . 2008;17:348–356 12. Hakki S, Ap ikyan AG, Yildi im S, Aydinbelge M, Gokalp A, Uca C, Gu an S, Koseoglu V, A aoglu T, Some man MJ. Pe iodon al s a us in wo sinblings wi h se e e congeni al neu openia: diagnosis and mu a ional analysis o he cases. J Pe iodon ol 2005;76: 837-844. 13. Kinane D. Blood and lympho e icula diso de s. Pe iodon ol 2000 1999; 21:84-93. 14. Hei z- May ield Lisa J.A, Lang Niklaus P. Compa a i e biology o ch onic and agg essi e pe iodon i is s pe i-implan i is. Pe iodon ology 2000. Vol 53,2010,167-181. 15. De aia E, Ma ielli A. O al mani es a ion o congeni al neu opania o Kos mann synd ome. J Clin Pedia Den . 2001;26 :99-102. 16. Goul schin J, A al U, Golds ein M, Boyan BD, Schwa z Z. The ela ionship be ween pe iphe al le els o leukocy es and neu ophils and pe iodon al disease s a us in a pa ien wi h congeni al neu openia. J Pe iodon ol 2000;71:1499-1505. 17. Vi ko L, Klappache M, Hanning M, K au ga ne WD. Ex acellula neu ophils aps in pe iodon i is. J Pe iodon Res 2009; 44: 664-672. 18. Alsaadi G, Qui ynen M, Komá ek A, an S eenbe ghe D. Impac o local and sys emic ac o s on he incidence o o al implan ailu es, up o abu men connec ion. Jou nal o clinical Pe iodon ology 2007; 34: 610-617. FIGURES Figu e 1. – Ini ial pano amic X- ay, i e mon hs a e inse ion o jaw implan s. TABLES Sample ype Cu aneous abscess / so issue G am inc ion > 25 PMN, absence o epi helial cells Ae obic cul u e S ep ococcus in e medius is isola ed Anae obic cul u e P e o ella sp is isola ed An ibio ics S ep ococcus in e medius P e o ella sp Desc ip ion Values M.I.C Values M.I.C Clindamycin S - R - E y h omycin S - - - Penicillin S - R - Vancomycin S - - - Amoxicyllin / Cla ulanic acid - - S - Imipinem - - S - Moxi loxacyn - - S - Me onidazole - - S - Table 1. Mic obiologic analysis and an ibiog am o pa ien s a admission. (M. I. C Minimum inhibi o y concen a ion – S Sensi i e – R Resis an ) Cell ype Values Uni s Range Leukocy es * 2.78 x10e9/L [3.8-11.5] Neu ophils * 0.0 x10e9/L [2.5-7.5] Neu ophils % * 0.0 % [25-65] Lymphocy es 1.5 x10e9/L [1.5-4] Lymphocy es % * 53.2 % [20-53] Monocy es 0.8 x10e9/L [0.2-0.8] Monocy es % * 27.7 % [2.5-11.5] Eosinophils 0.47 x10e9/L [0.05-0.5] Eosinophils % * 16.90 % [0.3-5] Basophils 0.06 x10e9/L [0.01-0.15] Basophils % * 2.2 % [0.6-1.8] Table 2.- Hemog am a admission